Senior insider sale
General Counsel at MAPLIGHT THERAPEUTICS, INC. — senior position signals high conviction
$903.6K
29.66K shares
What this filing means
HANSON KRISTOPHER plans to sell 29.66K shares of MAPLIGHT THERAPEUTICS, INC. valued at approximately $903.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/4/2026ACC: 0001974158-26-000063
Officer· General Counsel
Since Feb 2026
29.66K
Shares to sell
$903.6K
Approx. market value
27.83K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Vested RSU
N/A
7/5/2024
27.83KTotal acquired27.83K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/5/2024 | Vested RSU N/A | 27.83K | — |
| Total | 27.83K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
298.00
Market value
$8.2K
4/16/2026
—Completed
Units to sell
1.53K
Market value
$41.0K
4/15/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
27.83K
Market value
$854.5K
5/4/2026
Total
Units
29.66K
Value
$903.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/16/2026 | 298.00 | $8.2K | — | Completed |
4/15/2026 | 1.53K | $41.0K | — | Completed |
| Planned — Approximate Date | ||||
5/4/2026 | 27.83K | $854.5K | Nasdaq | Planned |
| Total | 29.66K | $903.6K | ||